News

New Study Clarifies BRCA Mutations in Ovarian Cancer, Encou...

New Study Clarifies BRCA Mutations in Ovarian Cancer, Encourages Testing

June 25, 2012

06/25/2012 Writing in the Journal of Clinical Oncology, Australian researchers suggest because BRCA mutation status impacts survival and treatment response, all women with nonmucinous ovarian cancer, regardless of family history, should be offered BRCA1/2 mutation testing. Researchers from the Peter MacCallum Cancer Centre in East Melbourne, Australia, screened 1,001 women with ovarian cancer to investigate … Continued

Research

New Study on BRCA Mutation in Women with Ovarian Cancer

New Study on BRCA Mutation in Women with Ovarian Cancer

June 21, 2012

A new study of 1,001 women with ovarian cancer found that 14% of them carried a BRCA1 or BRCA2 mutation. However, 44% of those women did not have a family history of breast or ovarian cancer. The BRCA mutations can not only help evaluate risk of developing ovarian cancer, but may direct treatment and can … Continued

Research

Cancer Survivors Need Long Term Care

Cancer Survivors Need Long Term Care

June 18, 2012

A new article explores the long term effects of cancer care, and the unique needs of survivors. With 18 million cancer survivors expected to be alive in the United States by 2022, this follow up care is important. It may require more education of a primary care provider and/or coordination between the oncologist and primary … Continued

Research

Partner Member Profile: The Ovarian Cancer Circle/Inspired ...

Partner Member Profile: The Ovarian Cancer Circle/Inspired by Robin Babbini

June 3, 2012

Like many Partner Members of the Alliance, the Ovarian Cancer Circle/Inspired by Robin Babbini was founded in memory of a particular woman with ovarian cancer. What sets Robin apart is her age at diagnosis: 17. “Our family didn’t know the symptoms,” recalls her mother, Paulinda Babbini. “A full year passed from Robin’s earliest symptoms to … Continued

Community

PARP Inhibitor Olaparib Increases Progression Free Survival

PARP Inhibitor Olaparib Increases Progression Free Survival

May 29, 2012

05/29/2012 In an abstract that will be presented at the American Society of Clinical Oncology annual meeting in Chicago this weekend, researchers report that in patients with platinum-sensitive recurrent serous ovarian cancer, olaparib plus paclitaxel plus carboplatin, followed by maintenance treatment with olaparib, resulted in a significant improvement in progression-free survival compared with paclitaxel plus … Continued

Research

Obesity Does Not Increase Risk for Ovarian Cancer Recurrence

Obesity Does Not Increase Risk for Ovarian Cancer Recurrence

May 29, 2012

05/29/2012 Research that will be presented at the 2012 American Society of Clinical Oncology meeting June 1-5th suggests that obesity did not affect recurrence, time to recurrence, or progression-free survival in women with epithelial ovarian cancer following surgery and chemotherapy. Previous research examining the relationship between obesity and ovarian cancer has yielded mixed results. Click … Continued

Research

Removing Fallopian Tubes Reduces Risk of Ovarian Cancer

Removing Fallopian Tubes Reduces Risk of Ovarian Cancer

May 11, 2012

Based on data showing that removing a woman’s fallopian tubes removes her risk of developing ovarian cancer, doctors are now urging women who are having their tubes tied to have them removed, instead. There is an increasing body of evidence suggesting that ovarian cancer may start in the fallopian tubes. Surgery to remove the fallopian … Continued

Research

RedCannon Security, Inc. and Ovarian Cancer Research Fund (...

RedCannon Security, Inc. and Ovarian Cancer Research Fund (OCRF) launch “Support Ovarian Cancer Research, Prevent Application Downtime” 90-day fundraiser campaign!!

May 8, 2012

FREMONT, CA AND NEW YORK, NY – May 8, 2012 – RedCannon Security, Inc. announced today that together with Ovarian Cancer Research Fund (OCRF), they are launching a limited time (90-day) fundraising campaign to help OCRF raise up to $500K for much-needed ovarian cancer research. As part of the campaign, RedCannon will provide licenses of … Continued

Community

Partner Member Profile: Ovarian Cancer Together

Partner Member Profile: Ovarian Cancer Together

May 1, 2012

In November 2006, Kay Kerbyson was diagnosed with ovarian cancer. A young mother of twins, Kay lived with her family in the small town of Los Alamos, New Mexico. She had to travel 100 miles to Albuquerque for her treatments. When her cancer recurred in January 2008, Kay wanted to talk to other ovarian cancer … Continued

Community

Ovarian Cancer National Alliance Submits Comments to Govern...

Ovarian Cancer National Alliance Submits Comments to Government Regarding Ovarian Cancer Screening

May 1, 2012

Posted by Cara on May 1, 2012 The Ovarian Cancer National Alliance submitted the following comments in response to the United States Preventive Service Task Force request for comments on draft recommendations for ovarian cancer screening. The comments can be found as a pdf online. Comments to USPSTF re: Draft Reaffirmation Recommendation Statement Screening for Ovarian Cancer: U.S. Preventive Services … Continued

Advocacy

DNA Repair Genes May be a Predictor of Ovarian Cancer Survival

DNA Repair Genes May be a Predictor of Ovarian Cancer Survival

April 30, 2012

04/30/2012   Research published this month in the Journal of the National Cancer Institute suggests that DNA repair genes may be a predictor of ovarian cancer survival. Researchers at Dana-Farber Cancer Institute in Boston used gene expression data from The Cancer Genome Atlas database to develop a molecular “score” by looking at genes involved in … Continued

Research

Increased BMI and Height Tied to Ovarian Cancer Risk

Increased BMI and Height Tied to Ovarian Cancer Risk

April 16, 2012

04/16/2012 Research reported in the journal PLoS Medicine finds that a woman’s Body Mass Index (BMI) and height are both tied to her risk for ovarian cancer.  Regardless of a woman’s height and size, her risk of developing ovarian cancer remains very small. Researchers from the United Kingdom included data from more than 25,000 women … Continued

Research